Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 245,638,592
  • Shares Outstanding, K 5,613,314
  • Annual Sales, $ 100,330 M
  • Annual Income, $ 31,372 M
  • 60-Month Beta 0.62
  • Price/Sales 2.47
  • Price/Cash Flow 5.98
  • Price/Book 2.66
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 22.05% ( +0.71%)
  • Historical Volatility 23.25%
  • IV Percentile 2%
  • IV Rank 3.60%
  • IV High 41.14% on 02/07/22
  • IV Low 21.34% on 02/03/23
  • Put/Call Vol Ratio 1.08
  • Today's Volume 110,748
  • Volume Avg (30-Day) 131,097
  • Put/Call OI Ratio 1.11
  • Today's Open Interest 1,411,373
  • Open Int (30-Day) 1,523,827

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate 1.06
  • Number of Estimates 5
  • High Estimate 1.25
  • Low Estimate 0.75
  • Prior Year 1.62
  • Growth Rate Est. (year over year) -34.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.70 +2.48%
on 01/31/23
50.26 -12.93%
on 01/09/23
-7.16 (-14.06%)
since 01/06/23
3-Month
42.70 +2.48%
on 01/31/23
54.93 -20.33%
on 12/14/22
-3.46 (-7.33%)
since 11/04/22
52-Week
41.44 +5.59%
on 10/11/22
56.32 -22.30%
on 04/11/22
-9.24 (-17.43%)
since 02/04/22

Most Recent Stories

More News
BiondVax (NASDAQ: BVXV) Aiming to Capture Market Share for Treatment, Prevention of COVID-19

The Food and Drug Administration (“FDA”) recently withdrew the authorization of AstraZeneca PLC (NASDAQ: AZN) ’s Evusheld, a combination of two monoclonal antibodies (“mAbs”), which was being...

BVXV : 2.79 (+5.28%)
PFE : 43.76 (-0.68%)
AZN : 63.52 (+0.13%)
The Most Active Stocks to Buy on Wall Street This Week

Amid concerns that an estimate-beating labor market tightness may embolden the Fed to keep pushing interest rates upward, fundamentally strong stocks Pfizer (PFE), Verizon (VZ), and AT&T (T) have deservedly...

PFE : 43.76 (-0.68%)
T : 19.58 (-1.26%)
VZ : 41.28 (-0.55%)
ACG appoints Rafael Costa as Vice President Sales for the Americas Region

/CNW/ -- ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is pleased to announce...

PFE : 43.76 (-0.68%)
5 Stocks That Moved the Market in January

These stocks illustrate the most important trends in the stock market right now.

TSLA : 194.76 (+2.52%)
NVDA : 210.89 (-0.05%)
SQ : 82.55 (-2.55%)
ABNB : 118.35 (-0.29%)
PFE : 43.76 (-0.68%)
Is Gilead Sciences a Good Stock to Buy Now?

Gilead Sciences' breast cancer drug, Trodelvy, just took a big step forward.

PFE : 43.76 (-0.68%)
DSNKY : 30.8200 (-0.61%)
GILD : 86.36 (+2.20%)
AZN : 63.52 (+0.13%)
Better Buy: Novavax or BioNTech Stock?

The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.

PFE : 43.76 (-0.68%)
BNTX : 140.96 (-0.77%)
NVAX : 11.09 (-1.25%)
The Safest Stock to Buy on Wall Street Right Now

With the recent market rally hinged on hopes of an end to the Fed’s hawkishness in the foreseeable future, strong fundamentals of Pfizer (PFE) for excellent value could help investors secure decent risk-adjusted...

ABBV : 145.02 (-0.12%)
BMY : 74.53 (+0.11%)
JNJ : 163.36 (-0.76%)
PFE : 43.76 (-0.68%)
3 Stocks to Buy if You're Building a Portfolio From Scratch

Shares of Pfizer (PFE), Centene (CNC), and Kellogg (K) could provide a solid foundation to new portfolios for sustained wealth creation, given the fundamental strength, consistent profitability, and resilient...

CNC : 71.01 (unch)
K : 69.01 (+2.07%)
PFE : 43.76 (-0.68%)
Is It Time to Buy the S&P 500's 3 Worst-Performing January Stocks?

It's safe to go bargain-hunting again. Just make sure the bargain is a stock you actually want to own for the long haul.

PFE : 43.76 (-0.68%)
ENPH : 222.99 (+0.03%)
NOC : 448.96 (+1.89%)
Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits

Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and others report fourth-quarter results. An appeals court dismisses J&J's (JNJ) bankruptcy filing related to its talc lawsuits.

SNY : 45.86 (-0.35%)
JNJ : 163.36 (-0.76%)
PFE : 43.76 (-0.68%)
MRK : 104.03 (+1.06%)
LLY : 337.66 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 44.71
2nd Resistance Point 44.50
1st Resistance Point 44.13
Last Price 43.76
1st Support Level 43.56
2nd Support Level 43.35
3rd Support Level 42.98

See More

52-Week High 56.32
Fibonacci 61.8% 50.64
Fibonacci 50% 48.88
Fibonacci 38.2% 47.13
Last Price 43.76
52-Week Low 41.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar